I work at amgen. ask me anthing. I'll answer honestly

Quote
anonymous said:
Chemocentryx is rare disease but also at much lower stakes. Tavenos does 6 million a quarter in sales where our portfolio is doing billions. They really don't compare. No company buys another to lose money on the purchase. They want to expand it not shut it down. At worse keep the cash cow steady.
Click to expand...


What? This entire comment makes zero sense. How does not letting Horizon operate independently equate to losing money? Shut down what? Expand what? Expand the sales force for rare disease when we just did that for 2 BUs? Amgen has had other large acquisitions & have never let them operate completely independently. As TW stated, Amgen is requiring Horizon to give approval for any significant expenditures. They didn’t even want to pay for a national meeting. Call me crazy, but that doesn’t sound like any form of independence. It is beyond arrogant to think that we need to operate separately to continue to make as much money. It’s just plain stupid to believe that Amgen would believe that.
 






anonymous said:
Chemocentryx is rare disease but also at much lower stakes. Tavenos does 6 million a quarter in sales where our portfolio is doing billions. They really don't compare. No company buys another to lose money on the purchase. They want to expand it not shut it down. At worse keep the cash cow steady.
Click to expand...


When Amgen bought Immunex for Enbrel, they did not allow them to operate independently. That was a HUGE deal at the time. In fact, they immediately converted Immunex HQ to a research outpost. If it helps you sleep better at night, keep believing that Horizon will get to keep operating separately.
 






anonymous said:
When Amgen bought Immunex for Enbrel, they did not allow them to operate independently. That was a HUGE deal at the time. In fact, they immediately converted Immunex HQ to a research outpost. If it helps you sleep better at night, keep believing that Horizon will get to keep operating separately.
Click to expand...

That's because enbrel was owned and controlled by Wyeth and immunex had the copromote only in the USA.
 






anonymous said:
What? This entire comment makes zero sense. How does not letting Horizon operate independently equate to losing money? Shut down what? Expand what? Expand the sales force for rare disease when we just did that for 2 BUs? Amgen has had other large acquisitions & have never let them operate completely independently. As TW stated, Amgen is requiring Horizon to give approval for any significant expenditures. They didn’t even want to pay for a national meeting. Call me crazy, but that doesn’t sound like any form of independence. It is beyond arrogant to think that we need to operate separately to continue to make as much money. It’s just plain stupid to believe that Amgen would believe that.
Click to expand...

If Amgen just takes over and does what Amgen normally does, operates like Amgen normally does- most of our products with tank. Even if they don't tank they definitely aren't growing which is why Amgen bought us. Letting us run independently for a while makes the most strategic sense for Amgen. You don't mess up a good thing.
 






anonymous said:
If Amgen just takes over and does what Amgen normally does, operates like Amgen normally does- most of our products with tank. Even if they don't tank they definitely aren't growing which is why Amgen bought us. Letting us run independently for a while makes the most strategic sense for Amgen. You don't mess up a good thing.
Click to expand...

Amgen's formula is to talk kindly, but slowly and innocuously force a culture of teleconferences and management book buzzwords onto you. The IC plan will be flattened so that the top performers make very similar to the bottom performers.

Their ultimate formula is when times are tough, instead of actually adjusting to the market, they will pay a vendor to run an analysis where the conclusion is.....wait, wait.....make more calls against A and B rheumatology targets....even if they don't exist. All they know is accounting. They are a massive bank and they count money. They are not a marketing machine.

Get used to teleconferences. At least 3 a week and usually when you should be doing a lunch.
 






anonymous said:
If Amgen just takes over and does what Amgen normally does, operates like Amgen normally does- most of our products with tank. Even if they don't tank they definitely aren't growing which is why Amgen bought us. Letting us run independently for a while makes the most strategic sense for Amgen. You don't mess up a good thing.
Click to expand...


It does not make the most sense TO Amgen. Do you seriously think that THEY think that the way that they operate is the wrong way? Funniest crap I’ve heard all day. Yeah, that’s EXACTLY why any significant decisions have to be run through Amgen now. I want what you are smokin’, dude.
I’m not saying that they are going to come in and change every damn thing right off the bat, but we WILL have to fit into their roles/pay band/bonus structure. We WILL get fleet cars, switch to their expense system, insurance, follow their compliance rules, etc.


Just curious as to how you think that they’re going to save $500 million by year 3 by letting us continue to operate independently? And please don’t say that’s not a lot of money. That was the sales for KXX in 2021. It’s a lot of damn money.
 






I have a feeling we will be the start of a new division at Amgen. A lot will change but they will also keep much of what we are doing. I doubt anyone takes much of a payout vs our incentive plan at goal. If they give company cars we might be given the option to.continue with our car allowance as it saves them money.

I'm personally excited as it opens up another realm of opportunity for top performers!
 






While losing the money would suck, I’m all for a company car. Less responsibility. Some companies offer nice cars, I came from Genentech and we had Mercedes, fully loaded Jeep Grand Cherokee, and Audis as car options
 






anonymous said:
I have a feeling we will be the start of a new division at Amgen. A lot will change but they will also keep much of what we are doing. I doubt anyone takes much of a payout vs our incentive plan at goal. If they give company cars we might be given the option to.continue with our car allowance as it saves them money.

I'm personally excited as it opens up another realm of opportunity for top performers!
Click to expand...

OP here- this is definitely a possibility and has been discussed. I think the likelihood of it is pretty high.

I know this is stressful especially over the holidays. i will let you know more information as I find out.
 






anonymous said:
I have a feeling we will be the start of a new division at Amgen. A lot will change but they will also keep much of what we are doing. I doubt anyone takes much of a payout vs our incentive plan at goal. If they give company cars we might be given the option to.continue with our car allowance as it saves them money.

I'm personally excited as it opens up another realm of opportunity for top performers!
Click to expand...
It wouldn't be inaccurate to assume that I couldn't exactly not say that it is or isn't almost partially incorrect.

On the contrary, I'm possibly more or less not definitely rejecting the idea that in no way with any amount of uncertainty that I undeniably...
 






anonymous said:
I have a feeling we will be the start of a new division at Amgen. A lot will change but they will also keep much of what we are doing. I doubt anyone takes much of a payout vs our incentive plan at goal. If they give company cars we might be given the option to.continue with our car allowance as it saves them money.

I'm personally excited as it opens up another realm of opportunity for top performers!
Click to expand...

(OP here) We are looking at all available options. Will keep you in the loop
 


















anonymous said:
This is the real OP. I apologize for the trolls. As the only sales representative on the transition team, I'll keep you abreast as we make decisions. Godspeed.
Click to expand...

(I'm the real OP)- no sales representatives are on the "transition team". We don't have an official team yet and won't until closer to the closing date. I have been in high level discussions and only ideas have been thrown around. No decisions have been made or will be made till after the sale closes.

And as I previously stated keeping horizon mainly intact and having that serve as our rare disease has some traction.
 






anonymous said:
(I'm the real OP)- no sales representatives are on the "transition team". We don't have an official team yet and won't until closer to the closing date. I have been in high level discussions and only ideas have been thrown around. No decisions have been made or will be made till after the sale closes.

And as I previously stated keeping horizon mainly intact and having that serve as our rare disease has some traction.
Click to expand...
(No, I'm the real OP)- why are you trying to take the credit?
 






























anonymous said:
I have a feeling we will be the start of a new division at Amgen. A lot will change but they will also keep much of what we are doing. I doubt anyone takes much of a payout vs our incentive plan at goal. If they give company cars we might be given the option to.continue with our car allowance as it saves them money.

I'm personally excited as it opens up another realm of opportunity for top performers!
Click to expand...

Well, since you have feelings & a lack of doubt, we should just throw out anything that Amgen or any other larger pharma company has done historically. Sure, we are so special that we will get the option of fleet car OR allowance, since that happens pretty much at no other company, especially one the size of Amgen. Oh, and they just had the reps from the other rare disease company that they bought order their fleet cars (knowing that they were trying to buy us).

Dang, I have never seen such unrealistic expectations as I have from some people on here. Also, you are already are going to take a pay cut even if they don’t drop the target IC…ya know those RSUs that you get awarded yearly? Well, you’ll be lucky to get a $4k worth. ESPP is only 5% discount.
 






Top Bottom
Back
Quote